Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

被引:138
作者
Fiedler, Georg Martin [1 ]
Baumann, Sven [1 ]
Leichtle, Alexander [1 ]
Oltmann, Anke [1 ]
Kase, Julia [1 ]
Thiery, Joachim [1 ]
Ceglarek, Uta [1 ]
机构
[1] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany
关键词
D O I
10.1373/clinchem.2006.077834
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Peptidome profiling of human urine is a promising tool to identify novel disease-associated biomarkers; however, a wide range of preartalytical variables influence the results of peptidome analysis. Our aim was to develop a standardized protocol for reproducible urine peptidome profiling by means of magnetic bead (MB) separation followed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). Methods: MBs with defined surface functionalities (hydrophobic interaction, cation exchange, and metal ion affinity) were used for peptide fractionation of urine. Mass accuracy and imprecision were calculated for 9 characteristic mass signals (M-r, 1000-10000). Exogenous variables (instrument performance, urine sampling/storage conditions, freezing conditions, and freeze-thaw cycles) and endogenous variables (pH, urine salt and protein concentrations, and blood and bacteria interferences) were investigated with urine samples from 10 male and 10 female volunteers. Results: We detected 427 different mass signals in the urine of healthy donors. Within- and between-day imprecision in relative signal intensities ranged from 1% to 14% and from 4% to 16%. respectively. Weak cation-exchange and metal ion affinity MB preparations required adjustment of the urinary pH to 7. Storage time, storage temperature, the number of freeze-thaw cycles, and bacterial and blood contamination significantly influenced urine peptide patterns. Individual urine peptide patterns differed significantly within and between days. This imprecision was diminished by normalization to a urinary protein content of 3.5 mu g. Conclusion: This reliable pretreatment protocol allows standardization of preartalytical modalities and facilitates reproducible peptidome profiling of human urine by means of MB separation in combination with MALDI-TOF MS. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:421 / 428
页数:8
相关论文
共 32 条
[1]   The use of proteomics for the assessment of clinical samples in research [J].
Aldred, S ;
Grant, MM ;
Griffiths, HR .
CLINICAL BIOCHEMISTRY, 2004, 37 (11) :943-952
[2]   Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [J].
Baumann, S ;
Ceglarek, U ;
Fiedler, GM ;
Lembcke, J ;
Leichtle, A ;
Thiery, J .
CLINICAL CHEMISTRY, 2005, 51 (06) :973-980
[3]   Biomedical informatics for proteomics [J].
Boguski, MS ;
McIntosh, MW .
NATURE, 2003, 422 (6928) :233-237
[4]  
Celis JE, 2000, ELECTROPHORESIS, V21, P2115
[5]   Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations [J].
Diamandis, EP .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :367-378
[6]   Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [J].
Findeisen, P ;
Sismanidis, D ;
Riedl, M ;
Costina, V ;
Neumaier, M .
CLINICAL CHEMISTRY, 2005, 51 (12) :2409-2411
[7]   Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy [J].
Haubitz, M ;
Wittke, S ;
Weissinger, EM ;
Walden, M ;
Rupprecht, HD ;
Floege, J ;
Haller, H ;
Mischak, H .
KIDNEY INTERNATIONAL, 2005, 67 (06) :2313-2320
[8]   Proteomics: A new diagnostic frontier [J].
Hortin, GL ;
Jortani, SA ;
Ritchie, JC ;
Valdes, R ;
Chan, DW .
CLINICAL CHEMISTRY, 2006, 52 (07) :1218-1222
[9]   Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? [J].
Hortin, GL .
CLINICAL CHEMISTRY, 2005, 51 (01) :3-5
[10]   Size-selective extraction of peptides from urine for mass spectrometric analysis [J].
Hortin, GL ;
Meilinger, B ;
Drake, SK .
CLINICAL CHEMISTRY, 2004, 50 (06) :1092-1095